Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Liabilities

As of the most recent data (June 2026), DMAQR shows a total liabilities of $16M. That compares with $20M in the prior-year period — down 20.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAQR's total liabilities is now $16M (was $20M) — a 20.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition - Tradeable Rights - Oct 2026 is outperforming or lagging.

Tracking DMAQR's total liabilities over time shows whether Deep Medicine Acquisition - Tradeable Rights - Oct 2026 is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $20M in the prior-year period — down 20.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Deep Medicine Acquisition - Tradeable Rights - Oct 2026's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $16M) with ownership activity and broader fundamentals.